{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T00:33:15Z","timestamp":1793665995523,"version":"4.5.1"},"reference-count":20,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T00:00:00Z","timestamp":1706486400000},"content-version":"unspecified","delay-in-days":28,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["UG1 EY028518"],"award-info":[{"award-number":["UG1 EY028518"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["UG1 EY030417"],"award-info":[{"award-number":["UG1 EY030417"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["UG1 EY05924477"],"award-info":[{"award-number":["UG1 EY05924477"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"crossref","award":["Internal Stanford University Grant"],"award-info":[{"award-number":["Internal Stanford University Grant"]}],"id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Ophth"],"accepted":{"date-parts":[[2023,12,31]]},"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>It remains uncertain which endothelial keratoplasty (EK) technique yields the best outcomes while maintaining safety, particularly in eyes with coexisting ocular conditions. Moreover, the impact of endothelial cell loss (ECL) on long-term graft survival requires further investigation. Adjuvant ripasudil, a rho kinase inhibitor, may address the challenge of ECL in corneal transplantation. This paper presents the protocol for the Descemet Endothelial Thickness Comparison Trial 1 (DETECT 1), a multicentre, outcome-masked, randomised, placebo-controlled, four-arm clinical trial.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A total of 160 eligible patients with endothelial dysfunction will be enrolled from five participating sites in the USA. The patients will be randomly assigned in a 2\u00d72 factorial design to one of the following treatment groups: group 1\u2014ultrathin Descemet stripping endothelial keratoplasty (UT-DSAEK) plus topical ripasudil 0.4%; group 2\u2014UT-DSAEK plus topical placebo; group 3\u2014Descemet membrane endothelial keratoplasty (DMEK) plus topical ripasudil 0.4% and group 4\u2014DMEK plus topical placebo. Primary outcomes include the best spectacle-corrected visual acuity at 12 months and ECL at 12 months. Secondary outcomes include visual acuity at different time points, vision-related quality of life, endothelial cell morphology and cost-effectiveness.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The study outcomes will be analysed using mixed effects linear regression models, taking into account the treatment arms and relevant covariates. Adverse events, including rebubble procedures, graft failure and graft rejection, will be documented and analysed using appropriate statistical methods.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>DETECT I aims to provide evidence on the comparative effectiveness of UT-DSAEK and DMEK, as well as the potential benefits of adjuvant topical ripasudil in reducing ECL. The results of this trial will contribute to optimising corneal transplantation techniques and improving long-term graft survival, while also exploring the cost-effectiveness of these interventions. Dissemination of findings through peer-reviewed publications and national\/international meetings will facilitate knowledge translation and guide clinical practice in the field of corneal transplantation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Ethics and dissemination<\/jats:title>\n                  <jats:p>A data and safety monitoring committee (DSMC) has been empaneled by the NEI.All study protocols will be subject to review and approval by WCG IRB as the single IRB of record.This study will comply with the National Institute of Health (NIH) Data Sharing Policy and Policy on the Dissemination of NIH-Funded Clinical Trial Information and the Clinical Trials Registration and Results Information Submission rule. Data from the trial will be made available on reasonable request.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjophth-2023-001454","type":"journal-article","created":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T13:05:26Z","timestamp":1706533526000},"page":"e001454","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Descemet Endothelial Thickness Comparison Trial 1 (DETECT 1): outcome masked, placebo-controlled trial comparing two types of corneal transplant surgeries and effect of rho kinase inhibitors on endothelial cell loss protocol"],"prefix":"10.1136","volume":"9","author":[{"given":"Winston","family":"Chamberlain","sequence":"first","affiliation":[{"name":"Oregon Health & Science University, Portland, Oregon, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles C","family":"Lin","sequence":"additional","affiliation":[{"name":"Ophthalmology, Stanford University, Stanford, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer Y","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology & Vision Science, University of California Davis, Davis, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Gensheimer","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Geisel School of Medicine, Dartmouth, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9682-4941","authenticated-orcid":false,"given":"Jameson","family":"Clover","sequence":"additional","affiliation":[{"name":"Eye Bank, VisionGift, Portland, Oregon, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bennie H","family":"Jeng","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Scheie Eye Institute, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Varnado","sequence":"additional","affiliation":[{"name":"Ophthalmology, Stanford University, Stanford, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Abdelrahman","sequence":"additional","affiliation":[{"name":"F.I. Proctor Foundation at the University of California San Francisco, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin F","family":"Arnold","sequence":"additional","affiliation":[{"name":"F.I. Proctor Foundation at the University of California San Francisco, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M","family":"Lietman","sequence":"additional","affiliation":[{"name":"F.I. Proctor Foundation at the University of California San Francisco, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4905-2528","authenticated-orcid":false,"given":"Jennifer","family":"Rose-Nussbaumer","sequence":"additional","affiliation":[{"name":"Ophthalmology, Stanford University, Stanford, California, USA"},{"name":"F.I. Proctor Foundation at the University of California San Francisco, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,1,29]]},"reference":[{"key":"2025090109293890000_9.1.e001454.1","unstructured":"America EBAo . Eye banking statistical report 2015; 2016."},{"key":"2025090109293890000_9.1.e001454.2","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1001\/jamaophthalmol.2015.4776","article-title":"Global survey of corneal transplantation and eye banking","volume":"134","author":"Gain","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"2025090109293890000_9.1.e001454.3","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1097\/ICO.0b013e3182a0a307","article-title":"Evolution of endothelial Keratoplasty","volume":"32 Suppl 1","author":"Price","year":"2013","journal-title":"Cornea"},{"key":"2025090109293890000_9.1.e001454.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2015.08.017"},{"key":"2025090109293890000_9.1.e001454.5","unstructured":"America EBAo . 2014 eye banking statistical report; 2015."},{"key":"2025090109293890000_9.1.e001454.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2016.07.036"},{"key":"2025090109293890000_9.1.e001454.7","unstructured":"Chamberlain WD , Lin CC , Austin A , et al . Descemet endothelial thickness comparison trial: A randomized trial comparing Ultrathin DSAEK to DMEK. Ophthalmology 2018."},{"key":"2025090109293890000_9.1.e001454.8","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0000000000001697"},{"key":"2025090109293890000_9.1.e001454.9","unstructured":"Dickman MM , Suryan D , Robert W , et al . Preliminary results of a multicenter randomized clinical trial comparing Descemet membrane endothelial Keratoplasty (DMEK) with Ultrathin Descemet stripping automated endothelial Keratoplasty (UT-DSAEK). ARVO abstract 1576. Invest Ophthalmol Vis Sci 2018."},{"key":"2025090109293890000_9.1.e001454.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2011.06.002"},{"key":"2025090109293890000_9.1.e001454.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2015.07.003"},{"key":"2025090109293890000_9.1.e001454.12","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.12-11320"},{"key":"2025090109293890000_9.1.e001454.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2012.03.033"},{"key":"2025090109293890000_9.1.e001454.14","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.08-2634"},{"key":"2025090109293890000_9.1.e001454.15","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0b013e318285475d"},{"key":"2025090109293890000_9.1.e001454.16","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/ICO.0000000000001883","article-title":"Use of topical Rho kinase inhibitors in the treatment of Fuchs dystrophy after Descemet stripping only","volume":"38","author":"Macsai","year":"2019","journal-title":"Cornea"},{"key":"2025090109293890000_9.1.e001454.17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1712770"},{"key":"2025090109293890000_9.1.e001454.18","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2015-306837"},{"key":"2025090109293890000_9.1.e001454.19","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0b013e3181611c50"},{"key":"2025090109293890000_9.1.e001454.20","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1038\/eye.2008.393","article-title":"Descemet membrane endothelial Keratoplasty (DMEK) for Fuchs endothelial dystrophy: review of the first 50 consecutive cases","volume":"23","author":"Ham","year":"2009","journal-title":"Eye (Lond)"}],"container-title":["BMJ Open Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjophth-2023-001454","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T16:29:49Z","timestamp":1756744189000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjophth.bmj.com\/lookup\/doi\/10.1136\/bmjophth-2023-001454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1,29]]},"published-print":{"date-parts":[[2024,1]]}},"alternative-id":["10.1136\/bmjophth-2023-001454"],"URL":"https:\/\/doi.org\/10.1136\/bmjophth-2023-001454","relation":{},"ISSN":["2397-3269"],"issn-type":[{"value":"2397-3269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1]]}}}